Tissue Regenix Group plc Profit Margin

Tissue Regenix Group plc (TSSNF) currently reports a profit margin of -5.33% as of June 2024. That compares with -39.98% in the prior-year period — up 86.7% year over year. That is below the sector sector average of 22.52%. Use the charts on this page to explore Tissue Regenix Group plc's profit margin history and peer comparisons.

Tissue Regenix Group plc's profit margin increased from -39.98% to -5.33% — a 86.7% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tissue Regenix Group plc's profit margin of -5.33% is lower than the its sector sector average of 22.52%. That is roughly 123.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Tissue Regenix Group plc's current -5.33% should be judged against industry norms (sector average: 22.52%) and against TSSNF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -5.33%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 22.52%. From there, open related valuation or income-statement pages for Tissue Regenix Group plc, and consider following TSSNF for alerts when major investors trade the stock.